BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 1956787)

  • 21. The major histocompatibility complex class II promoter-binding protein RFX (NF-X) is a methylated DNA-binding protein.
    Zhang XY; Jabrane-Ferrat N; Asiedu CK; Samac S; Peterlin BM; Ehrlich M
    Mol Cell Biol; 1993 Nov; 13(11):6810-8. PubMed ID: 8413274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X.
    Reith W; Satola S; Sanchez CH; Amaldi I; Lisowska-Grospierre B; Griscelli C; Hadam MR; Mach B
    Cell; 1988 Jun; 53(6):897-906. PubMed ID: 3133120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y.
    Reith W; Siegrist CA; Durand B; Barras E; Mach B
    Proc Natl Acad Sci U S A; 1994 Jan; 91(2):554-8. PubMed ID: 8290561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional analysis of cis-linked regulatory sequences in the HLA DRA promoter by transcription in vitro.
    Hume CR; Lee JS
    Tissue Antigens; 1990 Sep; 36(3):108-15. PubMed ID: 2278044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptional regulation of the MHC II gene DRA in untransformed human thyrocytes.
    Wu Z; Biro PA; Mirakian R; Curcio F; Ambesi-Impiombato FS; Bottazzo GF
    Int Immunol; 2000 Apr; 12(4):405-13. PubMed ID: 10744641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human X-box-binding protein 1 is required for the transcription of a subset of human class II major histocompatibility genes and forms a heterodimer with c-fos.
    Ono SJ; Liou HC; Davidon R; Strominger JL; Glimcher LH
    Proc Natl Acad Sci U S A; 1991 May; 88(10):4309-12. PubMed ID: 1903538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. X-box-binding proteins positively and negatively regulate transcription of the HLA-DRA gene through interaction with discrete upstream W and V elements.
    Cogswell JP; Basta PV; Ting JP
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7703-7. PubMed ID: 2120707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conserved residues of the bare lymphocyte syndrome transcription factor RFXAP determine coordinate MHC class II expression.
    Long AB; Ferguson AM; Majumder P; Nagarajan UM; Boss JM
    Mol Immunol; 2006 Feb; 43(5):395-409. PubMed ID: 16337482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of class II expression in monocytic cells after HIV-1 infection.
    Rakoff-Nahoum S; Chen H; Kraus T; George I; Oei E; Tyorkin M; Salik E; Beuria P; Sperber K
    J Immunol; 2001 Aug; 167(4):2331-42. PubMed ID: 11490022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single base pair substitutions within the HLA-DRA gene promoter separate the functions of the X1 and X2 boxes.
    Sloan JH; Hasegawa SL; Boss JM
    J Immunol; 1992 Apr; 148(8):2591-9. PubMed ID: 1560213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel cysteine-rich sequence-specific DNA-binding protein interacts with the conserved X-box motif of the human major histocompatibility complex class II genes via a repeated Cys-His domain and functions as a transcriptional repressor.
    Song Z; Krishna S; Thanos D; Strominger JL; Ono SJ
    J Exp Med; 1994 Nov; 180(5):1763-74. PubMed ID: 7964459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of major histocompatibility class II gene expression in FRTL-5 thyrocytes: opposite effects of interferon and methimazole.
    Montani V; Shong M; Taniguchi SI; Suzuki K; Giuliani C; Napolitano G; Saito J; Saji M; Fiorentino B; Reimold AM; Singer DS; Kohn LD
    Endocrinology; 1998 Jan; 139(1):290-302. PubMed ID: 9421427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Affinity enrichment and functional characterization of TRAX1, a novel transcription activator and X1-sequence-binding protein of HLA-DRA.
    Itoh-Lindstrom Y; Peterlin BM; Ting JP
    Mol Cell Biol; 1995 Jan; 15(1):282-9. PubMed ID: 7799935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assembly of functional regulatory complexes on MHC class II promoters in vivo.
    Fontes JD; Jabrane-Ferrat N; Peterlin BM
    J Mol Biol; 1997 Jul; 270(3):336-45. PubMed ID: 9237901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of major histocompatibility (MHC) class II human leukocyte antigen-DR alpha gene expression in thyrocytes by single strand binding protein-1, a transcription factor that also regulates thyrotropin receptor and MHC class I gene expression.
    Balducci-Silano PL; Suzuki K; Ohta M; Saito J; Ohmori M; Montani V; Napolitano G; Shong M; Taniguchi SI; Pietrarelli M; Lavaroni S; Mori A; Singer DS; Kohn LD
    Endocrinology; 1998 May; 139(5):2300-13. PubMed ID: 9564838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-Y.
    Villard J; Peretti M; Masternak K; Barras E; Caretti G; Mantovani R; Reith W
    Mol Cell Biol; 2000 May; 20(10):3364-76. PubMed ID: 10779326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of EF-C/RFX-1 with the inverted repeat of viral enhancer regions is required for transactivation.
    David E; Garcia AD; Hearing P
    J Biol Chem; 1995 Apr; 270(14):8353-60. PubMed ID: 7713944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The transcription factor RFX protects MHC class II genes against epigenetic silencing by DNA methylation.
    Seguín-Estévez Q; De Palma R; Krawczyk M; Leimgruber E; Villard J; Picard C; Tagliamacco A; Abbate G; Gorski J; Nocera A; Reith W
    J Immunol; 2009 Aug; 183(4):2545-53. PubMed ID: 19620312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Major histocompatibility class II HLA-DR alpha gene expression in thyrocytes: counter regulation by the class II transactivator and the thyroid Y box protein.
    Montani V; Taniguchi SI; Shong M; Suzuki K; Ohmori M; Giuliani C; Napolitano G; Saji M; Fiorentino B; Reimold AM; Ting JP; Kohn LD; Singer DS
    Endocrinology; 1998 Jan; 139(1):280-9. PubMed ID: 9421426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients.
    Masternak K; Barras E; Zufferey M; Conrad B; Corthals G; Aebersold R; Sanchez JC; Hochstrasser DF; Mach B; Reith W
    Nat Genet; 1998 Nov; 20(3):273-7. PubMed ID: 9806546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.